RhumbLine Advisers’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84K Hold
1,200
﹤0.01% 3945
2025
Q4
$1.49K Hold
1,200
﹤0.01% 4010
2025
Q3
$2.42K Hold
1,200
﹤0.01% 3973
2025
Q2
$2.16K Sell
1,200
-39,277
-97% -$75.7K ﹤0.01% 3991
2025
Q1
$86.2K Buy
40,477
+3,043
+8% +$10.4K ﹤0.01% 3441
2024
Q4
$145K Buy
37,434
+1,542
+4% +$12.3K ﹤0.01% 3350
2024
Q3
$363K Sell
35,892
-346
-1% -$2.25K ﹤0.01% 2917
2024
Q2
$163K Buy
36,238
+8,272
+30% +$84.1K ﹤0.01% 3337
2024
Q1
$418K Buy
27,966
+608
+2% +$10K ﹤0.01% 2777
2023
Q4
$397K Sell
27,358
-85
-0.3% -$1.03K ﹤0.01% 2805
2023
Q3
$378K Buy
27,443
+45
+0.2% +$811 ﹤0.01% 2789
2023
Q2
$601K Buy
+27,398
New +$858K ﹤0.01% 2576
2022
Q2
Sell
-13,190
Closed -$59K 3109
2022
Q1
$59K Buy
+13,190
New +$85.6K ﹤0.01% 2961

Other funds holding BMEA

RhumbLine Advisers's BMEA Position: Q1 2026 in Review

RhumbLine Advisers held its Biomea Fusion (BMEA) position steady in Q1 2026 at 1,200 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #3945.

RhumbLine Advisers first reported a position in BMEA in Q1 2022 and has held it in 13 quarters since. The position peaked at $601K in Q2 2023. 65 funds tracked by Wall St. Rank hold BMEA as of Q1 2026.

  • RhumbLine Advisers held 1,200 shares of Biomea Fusion worth $1.84K as of Q1 2026.
  • RhumbLine Advisers left its Biomea Fusion share count unchanged in Q1 2026.
  • Biomea Fusion made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3945 holding.
  • RhumbLine Advisers first reported a position in Biomea Fusion in Q1 2022 and has held it in 13 quarters since.
  • RhumbLine Advisers's Biomea Fusion position peaked at $601K in Q2 2023.
  • 65 funds tracked by Wall St. Rank held Biomea Fusion as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.